The Current Ratio as of November 2024 (TTM) for Telix Pharmaceuticals Limited (TLPPF) is 0.99

According to Telix Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current Current Ratio is 0.99. This represents a change of -27.87% compared to the average of 1.37 of the last 4 quarters.

Telix Pharmaceuticals Limited (TLPPF) Historical Current Ratio (quarterly & annually)

How has TLPPF Current Ratio performed in the past?

The mean historical Current Ratio of Telix Pharmaceuticals Limited over the last ten years is 6.17. The current 0.99 Current Ratio has changed 1.50% with respect to the historical average. Over the past ten years (40 quarters), TLPPF's Current Ratio was at its highest in in the September 2017 quarter at 33.74. The Current Ratio was at its lowest in in the March 2023 quarter at 0.82.

Telix Pharmaceuticals Limited (TLPPF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Telix Pharmaceuticals Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Telix Pharmaceuticals Limited (TLPPF) Average Current Ratio

How has TLPPF Current Ratio performed in the past?

The current Current Ratio of Telix Pharmaceuticals Limited (TLPPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Telix Pharmaceuticals Limited (TLPPF) Current Ratio vs. Peers

How is TLPPF’s Current Ratio compared to its peers?

Telix Pharmaceuticals Limited’s Current Ratio is less than Genscript Biotech Corporation (4.15), less than Keros Therapeutics, Inc. (20.37), less than Zentalis Pharmaceuticals, Inc. (6.59), less than Innovent Biologics, Inc. (3.00), less than MAIA Biotechnology, Inc. (3.42), less than Graphite Bio, Inc. (11.47), less than Roivant Sciences Ltd. (27.91), greater than Field Trip Health & Wellness Ltd. (0), less than Nautilus Biotechnology, Inc. (16.65), less than Arcellx, Inc. (6.01), less than Ventyx Biosciences, Inc. (14.19), less than Immunocore Holdings plc (5.17), less than Vaxcyte, Inc. (17.88), less than DICE Therapeutics, Inc. (25.88),

Build a custom stock screener for Telix Pharmaceuticals Limited (TLPPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Telix Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Telix Pharmaceuticals Limited (TLPPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Telix Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.